In November 2017, Episurf Medical announced that a peer-reviewed article with clinical data on 10 Episealer® knee implant patients with 24 months’ follow-up was accepted for publication.

The publication with the title “No implant migration and good subjective outcome of a novel customized femoral resurfacing metal implant for focal chondral lesions” by Stålman, A., Sköldenberg, O., Martinez-Carranza, N., Roberts, D., Högström, M. and Ryd, L. will be published in the journal Knee Surgery, Sports Traumatology, Arthroscopy.

The study behind the publication is a multi-center clinical study conducted in Sweden with Dr Anders Stålman as principal investigator. The surgeries were performed between 2012 and 2014. The patients were followed-up with subjective outcome measures (VAS, Tegner, EQ5D and KOOS) and implant fixation was studied with RSA. The subjective outcome measures showed improvements that reached significance for VAS (p=<â€Š0,001), Tegner (p=0,034) and the KOOS sub-scores Activities of Daily Living (p=0,0048), Sport and Recreation (p=0,034) and Quality of Life (p=0,037).

“This publication is very welcome for us, as high-quality peer-reviewed clinical evidence is a must for orthopaedic surgeons in their treatment decisions. This is a further and very important step forward to gain market shares for the Episealer®” comments Pål Ryfors, CEO, Episurf Medical.